BDBM284388 6-(1-methyl-1H-pyrazol-4- yl)-4-(6-(4-(2- (trifluoromethoxy)ethyl) piperazin-1-yl)pyridin-3- yl)pyrazolo[1,5-a]pyridine- 3-carbonitrile::US10023570, Example 398::US10174027, Example 398

SMILES Cn1cc(cn1)-c1cc(-c2ccc(nc2)N2CCN(CCOC(F)(F)F)CC2)c2c(cnn2c1)C#N

InChI Key InChIKey=KTPQVBBNDDAOOV-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 284388   

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Array Biopharma

US Patent
LigandPNGBDBM284388(US10023570, Example 398 | 6-(1-methyl-1H-pyrazol-4...)
Affinity DataIC50: 11.1nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

LigandPNGBDBM284388(US10023570, Example 398 | 6-(1-methyl-1H-pyrazol-4...)
Affinity DataIC50: 11.1nMpH: 7.4Assay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/10/2019
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Array Biopharma

US Patent
LigandPNGBDBM284388(US10023570, Example 398 | 6-(1-methyl-1H-pyrazol-4...)
Affinity DataIC50: 11.1nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

LigandPNGBDBM284388(US10023570, Example 398 | 6-(1-methyl-1H-pyrazol-4...)
Affinity DataIC50: 108nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

LigandPNGBDBM284388(US10023570, Example 398 | 6-(1-methyl-1H-pyrazol-4...)
Affinity DataIC50: 108nMpH: 7.4Assay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/10/2019
Entry Details
US Patent

LigandPNGBDBM284388(US10023570, Example 398 | 6-(1-methyl-1H-pyrazol-4...)
Affinity DataIC50: 108nMAssay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent